KR20220080076A - 온도 응답성 이온 액체를 포함하는 의약 조성물 - Google Patents

온도 응답성 이온 액체를 포함하는 의약 조성물 Download PDF

Info

Publication number
KR20220080076A
KR20220080076A KR1020227007774A KR20227007774A KR20220080076A KR 20220080076 A KR20220080076 A KR 20220080076A KR 1020227007774 A KR1020227007774 A KR 1020227007774A KR 20227007774 A KR20227007774 A KR 20227007774A KR 20220080076 A KR20220080076 A KR 20220080076A
Authority
KR
South Korea
Prior art keywords
ion
temperature
ionic liquid
synthesis example
tetrabutylphosphonium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227007774A
Other languages
English (en)
Korean (ko)
Inventor
타카히로 모토시로미즈
마사후미 수도
수구루 타카키
미키토 히라카타
유리 카지와라
Original Assignee
도레이 카부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 도레이 카부시키가이샤 filed Critical 도레이 카부시키가이샤
Publication of KR20220080076A publication Critical patent/KR20220080076A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020227007774A 2019-10-11 2020-10-08 온도 응답성 이온 액체를 포함하는 의약 조성물 Pending KR20220080076A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2019-187274 2019-10-11
JP2019187274 2019-10-11
PCT/JP2020/038097 WO2021070893A1 (ja) 2019-10-11 2020-10-08 温度応答性イオン液体を含む医薬組成物

Publications (1)

Publication Number Publication Date
KR20220080076A true KR20220080076A (ko) 2022-06-14

Family

ID=75437270

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227007774A Pending KR20220080076A (ko) 2019-10-11 2020-10-08 온도 응답성 이온 액체를 포함하는 의약 조성물

Country Status (9)

Country Link
US (1) US20240058452A1 (https=)
EP (1) EP4043007A4 (https=)
JP (1) JP7322895B2 (https=)
KR (1) KR20220080076A (https=)
CN (1) CN114502142B (https=)
AU (1) AU2020362643B2 (https=)
BR (1) BR112022005324A2 (https=)
CA (1) CA3157143A1 (https=)
WO (1) WO2021070893A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024106024A1 (https=) * 2022-11-14 2024-05-23

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007022942A (ja) 2005-07-13 2007-02-01 Medorekkusu:Kk 常温性イオン性液体を含有する医薬組成物
WO2009066457A1 (ja) 2007-11-22 2009-05-28 Medrx Co., Ltd. 脂肪酸系イオン液体を有効成分とする外用剤組成物
WO2016068336A1 (ja) 2014-10-30 2016-05-06 旭化成ケミカルズ株式会社 経皮吸収促進剤及び経皮吸収促進助剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1705640A (zh) * 2002-08-16 2005-12-07 塞克姆公司 包含磺酸根阴离子的离子液体
US20060094616A1 (en) * 2004-11-01 2006-05-04 Hecht Stacie E Ionic liquids derived from surfactants
JP2008044849A (ja) * 2006-08-10 2008-02-28 Tokyo Univ Of Agriculture & Technology 温度制御により水と可逆的に相溶／相分離を示すイオン液体
US20100029704A1 (en) * 2007-01-29 2010-02-04 Medrx Co., Ltd. Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
EP2233138B1 (en) * 2007-12-11 2014-07-23 Medrx Co., Ltd. Tape preparation comprising etodolac in ionic liquid form
JP2009178617A (ja) * 2008-01-29 2009-08-13 Sanyo Chem Ind Ltd 熱応答性液体組成物
WO2009119836A1 (ja) * 2008-03-28 2009-10-01 アンジェスＭｇ株式会社 転写因子デコイを有効成分とする外用剤組成物
WO2010078300A1 (en) * 2008-12-29 2010-07-08 The Board Of Trustees Of The University Of Alabama Dual functioning ionic liquids and salts thereof
EP2744335B1 (en) * 2011-08-16 2018-10-10 Basf Se Composition comprising active ingredient, oil and ionic liquid
WO2014024896A1 (ja) * 2012-08-08 2014-02-13 株式会社メドレックス アゴメラチンを含有する貼付剤組成物
JPWO2015129527A1 (ja) * 2014-02-27 2017-03-30 株式会社 メドレックス プラミペキソールを含有する神経変性疾患の治療用貼付剤
CN105363360A (zh) * 2014-08-26 2016-03-02 中国科学院大连化学物理研究所 一种温度刺激响应智能化的微乳液体系及其应用
EP3251697A4 (en) * 2015-01-27 2018-08-22 Ajinomoto Co., Inc. Method for controlling skin penetration
CN106420610B (zh) * 2016-10-21 2019-06-11 昆明理工大学 一种离子液体微乳及其应用
CN109896992A (zh) * 2017-12-08 2019-06-18 武汉软件工程职业学院 制备离子液体的方法及其应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007022942A (ja) 2005-07-13 2007-02-01 Medorekkusu:Kk 常温性イオン性液体を含有する医薬組成物
WO2009066457A1 (ja) 2007-11-22 2009-05-28 Medrx Co., Ltd. 脂肪酸系イオン液体を有効成分とする外用剤組成物
WO2016068336A1 (ja) 2014-10-30 2016-05-06 旭化成ケミカルズ株式会社 経皮吸収促進剤及び経皮吸収促進助剤

Also Published As

Publication number Publication date
AU2020362643B2 (en) 2024-12-12
EP4043007A4 (en) 2023-11-08
JP7322895B2 (ja) 2023-08-08
CA3157143A1 (en) 2021-04-15
JPWO2021070893A1 (https=) 2021-04-15
WO2021070893A1 (ja) 2021-04-15
BR112022005324A2 (pt) 2022-06-14
US20240058452A1 (en) 2024-02-22
EP4043007A1 (en) 2022-08-17
CN114502142B (zh) 2023-05-09
CN114502142A (zh) 2022-05-13
AU2020362643A1 (en) 2022-05-05

Similar Documents

Publication Publication Date Title
KR101107031B1 (ko) 할로겐화된 선택적 안드로겐 수용체 모듈레이터 및 그의 사용방법
ES2640572T3 (es) Formulaciones parenterales mejoradas de agentes farmacéuticos lipófilos y procedimientos de preparación y uso de las mismas
EP2191827B1 (en) Antifungal composition
JP2006518328A (ja) 複素環選択的アンドロゲン受容体調節剤及びその使用方法
Zhou et al. Development of gliclazide ionic liquid and the transdermal patches: An effective and noninvasive sustained release formulation to achieve hypoglycemic effects
RS20060249A (sr) Transdermalna farmaceutska kompozicija
AU2009310437A1 (en) Topical composition comprising a combination of at least two penetration enhancing agents
KR20100127300A (ko) 전사 인자 디코이를 유효 성분으로 하는 외용제 조성물
JP6482570B2 (ja) 経皮吸収促進剤及び経皮吸収促進助剤
JP2012524814A (ja) １，２，４−チアジアゾール誘導体の安定的な局所組成物
WO2011050728A1 (zh) 一种稳定的雷沙吉兰组合物
WO2016177346A1 (zh) 一种卡巴他赛脂肪乳注射剂及其制备方法和用途
KR20120115991A (ko) 담체 조성물
JP6025732B2 (ja) ヒストンデアセチラーゼ阻害薬のための医薬製剤
JP7322895B2 (ja) 温度応答性イオン液体を含む医薬組成物
CN110386869A (zh) 布洛芬离子液体及其制备方法
US10828265B2 (en) Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery
US20180177800A1 (en) Composition for percutaneous absorption
US20050158371A1 (en) Novel external agent
WO2024106024A1 (ja) 温度応答性イオン液体、温度応答性イオン液体を含む経皮吸収促進剤又は経皮吸収促進助剤、及び温度応答性イオン液体を含む医薬組成物
JP2024163413A (ja) 吸収制御剤
JPH0525046A (ja) ニセルゴリン経皮吸収製剤
WO2022109052A1 (en) Flumazenil formulations for subcutaneous injection and methods of treatment using gaba receptor modulators
WO2017195897A1 (ja) 経皮製剤
JP2521091B2 (ja) カテコ−ルアミン類の外用製剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000